Screening of early diagnostic markers of gentamicin-induced acute kidney injury in canines
Published Online: Sep 13, 2019
Page range: 405 - 411
Received: Feb 07, 2019
Accepted: Jul 24, 2019
DOI: https://doi.org/10.2478/jvetres-2019-0048
Keywords
© 2019 J.-S. Zheng et al. published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Acute kidney injury (AKI) is characterised by a sudden decrease in glomerular filtration rate (8). In dogs, the mortality rate of AKI (about 50%) is closely related to the severity of kidney injury. The prognosis of AKI in dogs is influenced by the time of diagnosis and treatment (1). One of the main reasons for mortality due to AKI is the diagnosis coming too late, which is a missed opportunity for early intervention. This failure to make early diagnosis is attributable to the lack of a valuable early diagnostic marker for AKI in dogs. Conventional laboratory markers for AKI include blood urea nitrogen and serum creatinine (SCr) levels. However, any abnormality of these indices is only seen when the renal tubular epithelial cells have 70%–80% damage (12) and when the kidneys have already suffered serious degradation or have even failed. Moreover, SCr concentration is also related to the total muscle mass of the body, as closely as it is to severe kidney damage, and diseased animals with a low total muscle mass due to malnutrition might not show a significant increase in this biomarker (3). Therefore, the development and screening of early diagnostic markers is of great significance for early diagnosis and prognosis of AKI.
In this study, we established an AKI model by injecting experimental dogs with gentamicin and then performed comparative analysis for screening early diagnostic markers of canine AKI. This study was a preliminary exploration of early diagnostic and warning indicators of this renal impairment in dogs, meant to provide a scientific basis for further studies on early diagnosis of canine acute kidney injury.
Changes in plasma concentrations of renal injury markers before and after gentamicin administration
Time (h) | NGAL content (ng/mL) | Kim-1 content (pg/mL) | L-FABP content (pg/mL) | SCr content (μmol/L) |
---|---|---|---|---|
0 | 16.42 ± 2.55 | 29.35 ± 2.82 | 161.70 ± 9.77 | 72.50 ± 9.10 |
6 | 16.70 ± 2.83 | 27.97 ± 2.15 | 151.85 ± 18.24 | 71.29 ± 6.47 |
12 | 18.32 ± 2.27 | 29.51 ± 4.20 | 203.78 ± 43.31* | 71.79 ± 5.96 |
18 | 21.81 ± 2.86*** | 33.24 ± 5.60 | 204.86 ± 44.98* | 73.79 ± 5.49 |
24 | 24.43 ± 4.02*** | 31.11 ± 6.27 | 197.70 ± 55.87* | 71.07 ± 8.47 |
30 | 22.39 ± 3.88*** | 33.44 ± 6.47* | 158.91 ± 38.40 | 75.79 ± 6.17 |
36 | 22.11 ± 3.79*** | 39.04 ± 5.86*** | 191.15 ± 51.00 | 73.36 ± 4.03 |
42 | 22.13 ± 3.64*** | 51.64 ± 7.99*** | 192.49 ± 52.17 | 74.50 ± 11.80 |
50 | 22.89 ± 6.19*** | 57.95 ± 3.32*** | 179.70 ± 18.36 | 78.36 ± 8.08 |
56 | 20.85 ± 3.26** | 58.14 ± 4.56*** | 195.61 ± 60.94* | 74.93 ± 7.99 |
62 | 23.63 ± 3.17*** | 58.38 ± 5.07*** | 168.15 ± 42.62 | 76.50 ± 6.42 |
68 | 22.36 ± 2.37*** | 58.99 ± 6.45*** | 163.16 ± 33.00 | 75.29 ± 6.37 |
72 | 25.80 ± 2.69*** | 59.20 ± 6.22*** | 130.70 ± 33.27* | 78.50 ± 5.95 |
78 | 30.41 ± 4.60*** | 58.96 ± 5.46*** | 148.56 ± 37.39 | 82.00 ± 4.41* |
84 | 32.88 ± 3.63*** | 67.49 ± 8.58*** | 161.701 ± 9.77 | 87.00 ± 4.63* |
90 | 33.36 ± 7.26*** | 69.81 ± 8.73*** | 151.85 ± 18.24 | 84.92 ± 8.84* |
96 | 33.56 ± 7.80*** | 85.95 ± 9.20*** | 203.78 ± 43.31* | 93.75 ± 8.31*** |
102 | 37.89 ± 10.99*** | 90.51 ± 10.84*** | 204.86 ± 44.98* | 115.08 ± 16.75*** |
108 | 36.74 ± 3.39*** | 113.89 ± 28.50*** | 197.70 ± 55.87* | 129.00 ± 19.42*** |
* P < 0.05, ** P < 0.01, and *** P < 0.001, compared with the levels before injection

Pathological changes in canine kidneys before and after gentamicin administration (HE, 20 ×); a – control kidney tissue; b – appearance of the kidney tissue at the earliest SCr elevation; c – appearance of the kidney tissue after acute kidney injury was established
Tubular injury score (n = 2)
Group | Cortical area (score) | Medulla area (score) |
---|---|---|
Normal control | 0.20 ± 0.41 | 0.25 ± 0.44 |
Earliest SCr elevation | 1.50 ± 0.51 | 0.70 ± 0.46 |
Day of acute kidney injury establishment | 4.95 ± 0.22 | 0.73 ± 0.45 |

Ultrastructural changes in canine kidney tissues before and after gentamicin administration (1,700 ×) d – control kidney tissue; e – appearance of the kidney tissue at the earliest SCr elevation; f – appearance of the kidney tissue after acute kidney injury was established
Cutoff concentrations, sensitivity, specificity, and area under the ROC curve of NGAL and Kim-1
Variables | Area under the curve (AUC) | 95% confidence interval | Standard error |
---|---|---|---|
NGAL | 0.84 | 0.793–0.887 | 0.031 |
Kim-1 | 0.954 | 0.941–0.977 | 0.028 |

Area under the ROC curve for NGAL and Kim-1
NGAL, a component of special neutrophil particles, was discovered by Kjeldsen
Kim-1 has low basal expression in healthy kidneys. However, after hypoxia, a large number of epithelial tissues of renal proximal convoluted tubules can be found by urine test. This elevated Kim-1 expression is an effective indicator for renal ischaemia and hypoxia injury (5).
L-FABP belongs to a family of 15-kDa cytoplasmic proteins. L-FABP, which is involved in the conversion of long-chain amino acids into cells, can selectively bind the products of lipid peroxidation and decrease their toxicity. Therefore, its protective effect can serve as a potential biomarker for cell damage (6).
In the present study, canine kidney tissues showed mild renal injury at the earliest time when the SCr concentration was increased, and severe injury was observed when AKI was established. The SCr concentrations did not begin to increase significantly until 78 h, at which point the kidneys were already severely damaged. It can be seen that the traditional diagnostic indicator SCr was only significantly increased in case of severe kidney injury, because of which the disease would be diagnosed at a late stage in real veterinary practice, which diminishes the opportunity for positive treatment and intervention. Creatinine is a protein metabolite excreted by the kidneys. Its concentration is affected by non-renal factors such as protein and water intake and muscle mass. The limitations of these influencing factors preclude creatinine’s being an ideal diagnostic indicator for AKI.
In this study, we found that changes in plasma L-FABP concentrations before and after gentamicin injection were not associated with kidney damage. Plasma L-FABP concentration was not associated with the degree of renal injury. Therefore, this protein cannot be used as a diagnostic index for AKI.
The plasma concentrations of NGAL and Kim-1 were significantly increased at 18 and 30 h after gentamicin injection, respectively. At these time points, the results of HE staining and TEM showed mild renal damage, which suggested that NGAL and Kim-1 were synthesised and secreted at an early stage of AKI when the pathological changes were only mild. Compared with SCr concentration, NGAL and Kim-1 concentrations provided a quicker and more accurate indication of AKI. The changes in NGAL and Kim-1 concentrations were directly proportional to the extent of renal injury, suggesting that the elevated concentrations were an indication of the prognosis of AKI, which was consistent with the reports in literature (10, 14).
In the present study, plasma NGAL and Kim-1 concentrations were elevated in the AKI model. The specific mechanism for this increase might be related to the upregulation of NGAL expression in the kidneys; NGAL is then secreted into urine and freely filtered in the glomerulus, and reabsorbed through macrophage-dependent endocytosis in the proximal tubule; however, elevated plasma NGAL may be due to damage-related tubular leak-back or reduced glomerular filtration (13).
After renal injury, the part of Kim-1 located outside the cell membrane can be lysed, allowing it to rapidly enter the small lumen and thus become detectable in urine. The secretion of Kim-1 into urine is closely related to its concentration in plasma. As a marker of early renal injury, plasma Kim-1 concentration is not affected by hepatic toxicity and can, therefore, reflect the damage to proximal renal tubular epithelial cells (11).
In summary, in the presence of AKI, the plasma concentrations of NGAL and Kim-1 were elevated earlier than those of the conventional index SCr. This indicated that plasma NGAL and Kim-1 levels can be used as early-warning indicators of gentamicin-induced canine AKI. We speculate that respective plasma NGAL and Kim-1 concentrations > 25.31 ng/mL and > 48.52 pg/mL have predictive value for the occurrence of gentamicin-induced AKI.